{"task_id": "d79b7b832fbe785b", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 115/464)", "text": ",\ndiaphoresis,\ndelusions,\nparanoia,\n102\nToxicology\n\n--- Page 124 ---\nSYMPATHOMIMETIC SYNDROMES (CONT\u2019D)\nmydriasis, hyperreflexia), serious (seizures, coma,\narrhythmias, cardiovascular collapse)\nTREATMENTS\nsupportive\nmeasures,\nsedation\nwith benzodiazepines. Avoid b blockers (unopposed\na effect)\nCHOLINERGIC SYNDROMES\nCAUSES\norganophosphate and carbamate insecti\ncides,\npilocarpine,\nphysostigmine,\nedrophonium,\nsome mushrooms\nCLINICAL FEATURES\ncommon (delirium, saliva\ntion, lacrimation, miosis, diaphoresis, emesis, urinary\nand fecal incontinence), serious (pulmonary edema,\nseizures, coma)\nTREATMENTS\nsupportive measures, atropine\nMETHANOL AND ETHYLENE GLYCOL OVERDOSE\nSee METHANOL and ETHYLENE GLYCOL OVERDOSE\non p. 105\nACETAMINOPHEN OVERDOSE\nPATHOPHYSIOLOGY\n5%\nof\nacetaminophen\nis\nmetabolized\nto\nN acetyl p benzoquinoneimine\n(NAPQI) which is highly toxic to liver, but is normally\nrapidly inactivated via conjugation with glutathione.\nWith acetaminophen overdose, NAPQI accumulates\ndue to depletion of glutathione stores, causing hepa\ntic necrosis and acute kidney injury. N acetylcysteine,\nthe antidote, regenerates hepatic glutathione stores\nleading to enhanced conjugation and clearance of\nNAPQI. A single dose of 10 15 g acetaminophen\n(twenty 500 mg tablets) can produce liver injury.\nFulminant hepatic failure (FHF) usually associated\nwith >25 g\nwThe rule of 140\u2019sw toxic dose = 140 mg/kg,\nnomogram blood level vs. time (>140 mg/mL 4 h\nafter ingestion ! >5 mg/mL 24 h after ingestion).\nFirst dose of N acetylcysteine 140 mg/kg PO (IV\ninfusion may also be used: 150 mg/kg in 200 mL\nD5W over 15 min, then 50 mg/kg in 500 mL D5W\nover 4 h, then 100 mg/kg in 1L D5W over 16 h; may\ncontinue third stage until liver enzyme normaliza\ntion in FHF)\nCLINICAL FEATURES\nfirst few hours, nausea and\nvomiting, RUQ pain, diarrhea. Symptoms disappear\n24 h after ingestion. Liver failure (\" INR, bilirubin, and\ntransaminases) may start at 24 72 h with or without\nAKI or cardiotoxicity\nPOOR PROGNOSTIC SIGNS\ncoagulopathy (most\nimportant), acidosis, acute kidney injury, hypopho\nsphatemia, encephalopathy\nTREATMENTS\nsupportive, N acetylcysteine\nKING\u2019S COLLEGE CRITERIA FOR LIVER TRANS\nPLANTATION IN TYLENOL OVERDOSE wThe rule\nACETAMINOPHEN OVERDOSE (CONT\u2019D)\nof 3\u2019sw\neither pH <7.3 or grade III/IV encephalo\npathy plus Cr >300 mmol/L [>3.3 mg/dL] plus INR\n>6.5 (\u00035% survival with medical therapy alone)\nNEJM 2008 359:3\nSALICYLATE OVERDOSE\nCAUSES (wThe rule of 3\u2019sw)\na single dose of\n10 30 g (30 tablets of 325 mg) can be fatal. Symp\ntoms may occur with salicylate >3.0 mmol/L\n[>40 mg/mL]\nCLINICAL FEATURES\ncommon (tinnitus, vertigo,\nN&V, diarrhea, tachypnea, metabolic acidosis, respira\ntory alkalosis), serious (hyperthermia, pulmonary\nedema, delirium, seizure, coma)\nDIAGNOSIS\nsalicylate\nlevel\n(every\n2 h\nuntil\ndecreased level), ABG (every 2 h until stable)\nTREATMENTS\nsupportive measures (avoid intu\nbation if possible. Consider gastric lavage. Glucose\n100 mL of D50W IV if altered mental status regardless\nof\nserum\nglucose\nlevel.\nActivated\ncharcoal\n(50 100 g PO/NG q4h \u00023doses). Alkalinize serum\nand urine; maintain urine pH 8 8.5 (NaHCO3 1 3\namps IV push, then 3 amps of NaHCO3 in 1 L D5W at\n250 mL/h). Consider hemodialysis if altered menta\ntion, cerebral edema, fluid overload, pulmonary\nedema, severe renal failure, salicylate >7.2 mmol/L\n[>100 mg/mL] in acute ingestion or >5 mmol/L\n[>70 mg/mL] in chronic toxicity, rising levels or clin\nical deterioration\nMORTALITY RATE\nacute \u00031 2% (usually suicidal\nattempt in young patient), chronic \u000325% (often\nelderly patient, delayed diagnosis due to low index\nof suspicion)\nOPIATE, SEDATIVE OR ETHANOL INTOXICATION\nSYNDROMES\nCAUSES\nnarcotics, barbiturates, benzodiazepines,\nethanol, clonidine\nCLINICAL FEATURES\ncommon (decrease in all\nvitals, hypothermia, stupor, miosis, dry skin, urinary\nretention, decreased bowel sounds, hyporeflexia),\nserious (seizures, coma, respiratory depression).\nNote vitals may be relatively normal, particularly for\nbenzodiazepine overdose\nTREATMENTS\nsupportive measures, naloxone (if\nopiates), flumazenil (if benzodiazepines), urinary\nalkalinization (if barbiturates)\nb BLOCKER OVERDOSE\nCLINICAL FEATURES\ncommon (hypotension, bra\ndycardia, bronchospasm, hypoglycemia), serious\n(shock, asystole, seizure, coma)\nTREATMENTS\nsupportive measures, fluid resusci\ntation, glucagon (initial dose 0.05 0.15 mg/kg up to\nToxicology\n103", "text_length": 4390, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 115/464)", "type": "chunk", "chunk_index": 114, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.402229", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.402921", "status": "complete", "chunks_added": 3}